AstraZeneca and Targacept Form Global Collaboration and Licence Agreement
- Details
- Category: AstraZeneca

Resource Guide About Key Issues Facing the Pharmaceutical Industry
- Details
- Category: Eli Lilly and Company

GSK's Arepanrix⢠H1N1 pandemic vaccine prequalified by the World Health Organization
- Details
- Category: GlaxoSmithKline

Merck KGaA Receives Refuse to File Letter from FDA on Cladribine Tablets New Drug Application
- Details
- Category: Merck Group

Pfizer And Protalix Enter Into Agreement To Develop And Commercialize Gaucher's Disease Treatment
- Details
- Category: Pfizer

"Positive Charge" to Help Address Barriers and Provide Support to People Living with HIV/AIDS
- Details
- Category: Bristol-Myers Squibb

Bayer Starts Phase III Trial with Florbetaben
- Details
- Category: Bayer

More Pharma News ...
- Bayer starts pivotal Phase III trial with Florbetaben
- Novartis gains rights to two oral targeted investigational therapies
- Lundbeck initiates clinical phase II trials with Lu AE58054
- FDA Grants IBsolvMIR Orphan Drug designation in the treatment of diabetes patients in the U.S.
- Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
- Merck KGaA to Expand Research and Development Presence in China
- Merck Receives CHMP Positive Opinion for New Fertility Treatment, ELONVA®